symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
XENO,0.0001,-23.24369,627,64582,0,1.0E-4-2.0E-4,0,Xeno Transplants Corporation,USD,,,,Other OTC,PNK,Biotechnology,,"Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.",Mr. Wayne  Smith,Healthcare,US,,617-566-5228,143 Gardner Road,Brookline,MA,02445,,0,https://financialmodelingprep.com/image-stock/XENO.png,2006-08-01,True,False,False,False,False
